Clinical Trial Update: Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial update examining the effects of replacing Lantus with Basalin on glycemic variation in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basalin (basal insulin analog)
• Lantus (insulin glargine)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type2 Diabetes | Phase 4 | Status: UNKNOWN